Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick W F Hadoke

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Cardiovascular Research|April 4, 2025
Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathyJoão P Monteiro, Diptarka Saha, Ana-Mishel Spiroski, et al.
Cardiovascular Research|September 16, 2021
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertensionJulie Rodor, Shiau Haln Chen, Jessica P Scanlon, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Circulation Research|March 11, 2021
MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular DiseaseJoão P Monteiro, Julie Rodor, Axelle Caudrillier, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Cardiovascular Research|April 4, 2025
Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathyJoão P Monteiro, Diptarka Saha, Ana-Mishel Spiroski, et al.
Cardiovascular Research|September 16, 2021
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertensionJulie Rodor, Shiau Haln Chen, Jessica P Scanlon, et al.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Circulation Research|March 11, 2021
MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular DiseaseJoão P Monteiro, Julie Rodor, Axelle Caudrillier, et al.
Pageof 9